A day prior, sources had told CNBC-TV18 that Jusmiral Holdings was to sell up to 5.1% of its stake in Cohance Lifesciences Ltd. via block deals.
A day prior, sources had told CNBC-TV18 that Jusmiral Holdings was to sell up to 5.1% of its stake in Cohance Lifesciences Ltd. via block deals.